Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Axelson

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1992
Burnout syndrome among oncologistsJ A Axelson, R H Clark
The Medical Clinics of North America|July 1, 1980
Immune Hemolytic anemiaJ A Axelson, A F LoBuglio
The New England Journal of Medicine|June 23, 1977
Meprobamate poisoning and pulmonary edemaJ A Axelson, J F Hagaman
The New England Journal of Medicine|June 23, 1994
CT scans and the common cold?M S Trimble, J A Axelson
Annals of Internal Medicine|October 1, 1987
Wegener granulomatosis and trimethoprim-sulfamethoxazoleJ A Axelson, R H Clark, S Ancerewicz
American Journal of Clinical Oncology|June 1, 1987
cis-platinum, 5-fluorouracil, and hydroxyurea in the treatment of advanced non-small-cell lung cancer. A phase II studyJ A Axelson, R H Clark, N V Dimitrov
The American Journal of the Medical Sciences|July 1, 1978
Case report. Brucella canis bacteremia: a case with negative B canis agglutininsG D Rifkin, R B Supena, J A Axelson
Journal of Biological Response Modifiers|December 1, 1984
Leukocyte interferon as a possible biological response modifier in lymphoproliferative disorders resistant to standard therapyR H Clark, N V Dimitrov, J A Axelson, et al.
American Journal of Clinical Oncology|February 1, 1989
A phase II trial of intermittent leukocyte interferon and high dose chlorambucil in the treatment of non-Hodgkin's lymphoma resistant to conventional therapyR H Clark, N V Dimitrov, J A Axelson, et al.
Journal of the National Cancer Institute|July 5, 2001
National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000P Eifel, J A Axelson, J Costa, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1992
Burnout syndrome among oncologistsJ A Axelson, R H Clark
The Medical Clinics of North America|July 1, 1980
Immune Hemolytic anemiaJ A Axelson, A F LoBuglio
The New England Journal of Medicine|June 23, 1977
Meprobamate poisoning and pulmonary edemaJ A Axelson, J F Hagaman
The New England Journal of Medicine|June 23, 1994
CT scans and the common cold?M S Trimble, J A Axelson
Annals of Internal Medicine|October 1, 1987
Wegener granulomatosis and trimethoprim-sulfamethoxazoleJ A Axelson, R H Clark, S Ancerewicz
American Journal of Clinical Oncology|June 1, 1987
cis-platinum, 5-fluorouracil, and hydroxyurea in the treatment of advanced non-small-cell lung cancer. A phase II studyJ A Axelson, R H Clark, N V Dimitrov
The American Journal of the Medical Sciences|July 1, 1978
Case report. Brucella canis bacteremia: a case with negative B canis agglutininsG D Rifkin, R B Supena, J A Axelson
Journal of Biological Response Modifiers|December 1, 1984
Leukocyte interferon as a possible biological response modifier in lymphoproliferative disorders resistant to standard therapyR H Clark, N V Dimitrov, J A Axelson, et al.
American Journal of Clinical Oncology|February 1, 1989
A phase II trial of intermittent leukocyte interferon and high dose chlorambucil in the treatment of non-Hodgkin's lymphoma resistant to conventional therapyR H Clark, N V Dimitrov, J A Axelson, et al.
Journal of the National Cancer Institute|July 5, 2001
National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000P Eifel, J A Axelson, J Costa, et al.
Pageof 1